speb/financial-data huggingface dataset:
4381.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 9194668.560352894
Net income (USD): -1992173.5062157465
Revenue growth %: -20.392376596608198
Smoothed growth %: -20.392376596608198
P/B ratio: 4.835455072687906
Pays dividend: no
Net asset value (USD): -3908468.1192353964
Net cash (USD): -4912317.871942254
Net cash to market cap %: -53.425719912558954
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.32916136541475394 (Distress Zone)
Piotroski F-score: 3 (Weak)
4381.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 6659784.984984985
Net income (USD): -5790634.384384384
Revenue growth %: -3.62370684596266
Smoothed growth %: -3.62370684596266
Pays dividend: no
Net asset value (USD): -2804116.6166166165
Net cash (USD): -3549818.568568568
Net cash to market cap %: -53.30229994769976
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1.86428891703773 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4388.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Communication Equipment
Lynch category:  (confidence: Low)
Market cap (USD): 26123298.686020453
P/B ratio: 2.868438118946197
Pays dividend: no
Net asset value (USD): 8783674.184059393
Net cash (USD): 1104398.375122566
Net cash to market cap %: 4.227637513916153
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4388.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Communication Equipment
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 19259831.23466114
P/B ratio: 1.1444007220394528
Pays dividend: no
Net asset value (USD): 11988163.347146103
Net cash (USD): 7664650.447801095
Net cash to market cap %: 39.79604158735999
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4388.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Communication Equipment
Lynch category:  (confidence: Low)
Market cap (USD): 18898768.517021865
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4388.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Communication Equipment
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 20322803.692126513
P/B ratio: 1.3926789650950442
Pays dividend: no
Net asset value (USD): 10195080.753701212
Net cash (USD): 7123169.582772545
Net cash to market cap %: 35.05013230793649
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4388.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Communication Equipment
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 13686952.552552553
P/E ratio: 0.14004443138301406
P/B ratio: 1.0877909492005666
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 10214358.108108107
Net cash (USD): 7207638.88888889
Net cash to market cap %: 52.66065518393792
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4394.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Technology | Industry: Information Technology Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 17493501.636388928
P/B ratio: 1.58203693867192
Pays dividend: no
Net asset value (USD): 10364751.70399221
Net cash (USD): 8177312.560856866
Net cash to market cap %: 46.74485835269774
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4394.T — Peter Lynch category analysis (quarterly, as of 2025-11-30)
Sector: Technology | Industry: Information Technology Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14716317.226388533
P/B ratio: 1.377272515908424
Pays dividend: no
Net asset value (USD): 9946275.915024316
Net cash (USD): 8017507.038648579
Net cash to market cap %: 54.48039013641268
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4394.T — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Sector: Technology | Industry: Information Technology Services
Lynch category:  (confidence: Low)
Market cap (USD): 15139538.140767356
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4394.T — Peter Lynch category analysis (quarterly, as of 2026-05-31)
Sector: Technology | Industry: Information Technology Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 20971099.84303384
P/E ratio: 0.11028254467861548
P/B ratio: 1.4968383249848676
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 9776655.992967915
Net cash (USD): 7905204.997802473
Net cash to market cap %: 37.69571008183634
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4406.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 70876652.18636289
Net income (USD): 7220127.8478937885
P/E ratio: 9.816537003155505
P/B ratio: 0.5088173854080132
Pays dividend: no
Net asset value (USD): 130322897.88559254
Net cash (USD): -160580232.74872974
Net cash to market cap %: -226.56294815745593
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5184185736993032 (Distress Zone)
Piotroski F-score: 3 (Weak)
4406.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 56611957.5018018
Net income (USD): -2980480.480480481
EPS growth %: -141.28016211444137
Revenue growth %: -6.278610800676443
Smoothed growth %: -141.28016211444137
P/B ratio: 0.4448273206252949
Pays dividend: no
Net asset value (USD): 118911411.41141142
Net cash (USD): -139977477.4774775
Net cash to market cap %: -247.25779438561614
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3693305606236725 (Distress Zone)
Piotroski F-score: 4 (Weak)
4406.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 44365019.79358162
Net income (USD): 2225303.7506603277
Revenue growth %: -12.687336144826613
EPS 2-year CAGR %: -44.4834836924754
Smoothed growth %: -12.687336144826613
P/E ratio: 19.93661304908012
P/B ratio: 0.36368077284507966
Pays dividend: no
Net asset value (USD): 113906497.62282091
Net cash (USD): -117696777.60169046
Net cash to market cap %: -265.291840619708
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3851421337600867 (Distress Zone)
Piotroski F-score: 8 (Strong)
4406.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46781006.020318136
Net income (USD): 3796283.9192621307
EPS growth %: 70.59621268043236
Revenue growth %: 0.7236228298251283
Smoothed growth %: 70.59621268043236
P/E ratio: 12.322841761901408
P/B ratio: 0.36850448145519643
PEG ratio: 0.174553864775766
Pays dividend: no
Net asset value (USD): 118680657.66608742
Net cash (USD): -104150514.63708061
Net cash to market cap %: -222.63419173124555
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6127421152332055 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4406.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46649491.09109109
Net income (USD): 4041541.5415415415
EPS growth %: 6.460465747437576
Revenue growth %: -8.105554947970017
EPS 2-year CAGR %: 34.7655455103705
Smoothed growth %: 34.7655455103705
P/E ratio: 0.07839822366006904
P/B ratio: 0.357116711494472
PEG ratio: 0.0022550551849296594
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 122804054.05405405
Net cash (USD): -85560560.56056055
Net cash to market cap %: -183.411562611667
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5424509308082823 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4409.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 80298226.60834289
Net income (USD): 11522701.19652516
P/E ratio: 6.968698158428164
P/B ratio: 0.5795912221679975
Pays dividend: no
Net asset value (USD): 126946402.22914277
Net cash (USD): -344877888.87067693
Net cash to market cap %: -429.4962708863169
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3420052893094334 (Distress Zone)
Piotroski F-score: 1 (Weak)
4409.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 70341135.70908408
Net income (USD): 7334834.8348348355
EPS growth %: -36.344484598396406
Revenue growth %: 1.6584149848326992
Smoothed growth %: -36.344484598396406
P/E ratio: 9.590009494831115
P/B ratio: 0.5274694182542362
Pays dividend: no
Net asset value (USD): 123521021.02102104
Net cash (USD): -331156156.1561562
Net cash to market cap %: -470.7859104319091
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.441707033026566 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4409.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 69126862.46962492
Net income (USD): 3605388.2725832015
EPS growth %: -50.84567882210006
Revenue growth %: -19.61483982198847
EPS 2-year CAGR %: -44.063038616714444
Smoothed growth %: -50.84567882210006
P/E ratio: 19.173208887179484
P/B ratio: 0.546433450903017
Pays dividend: no
Net asset value (USD): 118350501.84891707
Net cash (USD): -290702588.48388803
Net cash to market cap %: -420.5349094378843
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3477758500614188 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4409.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 92651308.85844138
Net income (USD): 10332843.202780377
EPS growth %: 186.5944642177766
Revenue growth %: 7.25187076028872
EPS 2-year CAGR %: 18.69016952540232
Smoothed growth %: 18.69016952540232
P/E ratio: 8.966681003492884
P/B ratio: 0.6577381301670147
PEG ratio: 0.4797538615851516
Pays dividend: no
Net asset value (USD): 133164015.5059484
Net cash (USD): -273265606.20237935
Net cash to market cap %: -294.9398228360617
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5650972520596569 (Distress Zone)
Piotroski F-score: 9 (Strong)
4409.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 96693993.1931932
Net income (USD): 9553303.303303303
EPS growth %: -7.544292351860271
Revenue growth %: -6.372942384497417
EPS 2-year CAGR %: 62.77989432756736
Smoothed growth %: 62.77989432756736
P/E ratio: 0.0654744526956039
P/B ratio: 0.6626557449102294
PEG ratio: 0.0010429207216243008
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 143668668.66866866
Net cash (USD): -258777527.52752754
Net cash to market cap %: -267.6252360480075
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5513469805146203 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4420.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Electronics & Computer Distribution
Lynch category:  (confidence: Low)
Market cap (USD): 74522078.19395803
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4420.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Electronics & Computer Distribution
Lynch category:  (confidence: Low)
Market cap (USD): 72508995.74813174
P/B ratio: 2.084360210524557
Pays dividend: no
Net asset value (USD): 34183109.60420703
Net cash (USD): 10319125.380570162
Net cash to market cap %: 14.231510551345686
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4420.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Electronics & Computer Distribution
Lynch category:  (confidence: Low)
Market cap (USD): 63903272.26370105
P/B ratio: 1.6923646694330294
Pays dividend: no
Net asset value (USD): 33647023.847580075
Net cash (USD): 5785454.894188352
Net cash to market cap %: 9.053456402536465
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4420.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Electronics & Computer Distribution
Lynch category:  (confidence: High)
Market cap (USD): 93546999.7997998
P/E ratio: 0.1061116422610491
Dividend yield: 0.01
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4422.T — Peter Lynch category analysis (annual, as of 2021-07-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 26544407.92432136
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4422.T — Peter Lynch category analysis (annual, as of 2022-07-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 17787958.86160714
Net income (USD): 247812.5
P/E ratio: 71.77990965591785
P/B ratio: 3.246564161932918
Pays dividend: no
Net asset value (USD): 5479010.416666666
Net cash (USD): 4382239.583333333
Net cash to market cap %: 24.635988971122444
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 7.360330449586113 (Safe Zone)
Piotroski F-score: 4 (Weak)
4422.T — Peter Lynch category analysis (annual, as of 2023-07-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 22416424.616368286
Net income (USD): 266140.94913327653
EPS growth %: 7.396095488837945
Revenue growth %: 2.945859489397624
Smoothed growth %: 7.396095488837945
P/E ratio: 84.22764211734557
P/B ratio: 4.045240238611713
PEG ratio: 11.388122590420908
Pays dividend: no
Net asset value (USD): 5541432.225063939
Net cash (USD): 4494479.965899403
Net cash to market cap %: 20.049941249852893
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 13.511235307359682 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4422.T — Peter Lynch category analysis (annual, as of 2024-07-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 16444117.842405189
Net income (USD): 22479.858518372963
EPS growth %: -91.553401086311
Revenue growth %: 2.917658345542019
EPS 2-year CAGR %: -69.88137215126724
Smoothed growth %: -91.553401086311
P/E ratio: 731.5045078671328
P/B ratio: 3.1792098600806153
Pays dividend: no
Net asset value (USD): 5172391.432501474
Net cash (USD): 3985557.083906465
Net cash to market cap %: 24.23697714953568
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 8.556603728907168 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4422.T — Peter Lynch category analysis (annual, as of 2025-07-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 10533916.967097769
Net income (USD): -551263.1508409837
EPS growth %: -2552.2536491518936
Revenue growth %: -10.122011171818116
Smoothed growth %: -10.122011171818116
P/B ratio: 2.2170021070297787
Pays dividend: no
Net asset value (USD): 4751423.97641225
Net cash (USD): 3393553.575018428
Net cash to market cap %: 32.21549577064301
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.851609992642643 (Safe Zone)
Piotroski F-score: 2 (Weak)
4432.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 881479637.0093199
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4432.T — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 610749294.7003721
P/B ratio: 2.0239450772361196
Pays dividend: no
Net asset value (USD): 16621634.800461952
Net cash (USD): -83546888.23302962
Net cash to market cap %: -13.679408057935941
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4432.T — Peter Lynch category analysis (quarterly, as of 2026-05-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: High)
Market cap (USD): 616622543.5549695
P/E ratio: 0.08518039153983101
Dividend yield: 0.04
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4476.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 43625166.35476541
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4476.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 44453617.824522555
P/B ratio: 3.579783426685181
Pays dividend: no
Net asset value (USD): 11631089.122612786
Net cash (USD): 6944969.554386936
Net cash to market cap %: 15.622956902634341
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4476.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 40301408.83276714
P/B ratio: 3.2385469233029958
Pays dividend: no
Net asset value (USD): 9886899.81458986
Net cash (USD): 4331327.920209705
Net cash to market cap %: 10.747336248672553
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4476.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 24430058.858858857
P/E ratio: 0.14253074934409213
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4484.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 34068520.180953935
Net income (USD): -5510317.980658908
P/B ratio: 3.4979353653863465
Pays dividend: no
Net asset value (USD): 6328364.20258974
Net cash (USD): -420037.6987379119
Net cash to market cap %: -1.2329202927127274
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4965385644854443 (Grey Zone)
Piotroski F-score: 1 (Weak)
4484.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Speculative (confidence: Low)
Market cap (USD): 36310580.788963966
Net income (USD): -1791478.9789789792
Revenue growth %: 8.13352152215159
Smoothed growth %: 8.13352152215159
P/B ratio: 5.051796081339383
Pays dividend: no
Net asset value (USD): 1134159.1591591593
Net cash (USD): -6160277.777777778
Net cash to market cap %: -16.96551705846054
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.442423726190805 (Grey Zone)
Piotroski F-score: 3 (Weak)
4484.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 30789943.102020603
Net income (USD): 733736.1331220286
Revenue growth %: -16.346793044637753
Smoothed growth %: -16.346793044637753
P/E ratio: 41.96323679877966
P/B ratio: 3.9460823209959077
Pays dividend: no
Net asset value (USD): 3012486.793449551
Net cash (USD): -3025310.3539355528
Net cash to market cap %: -9.82564450967438
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.577659215483922 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4484.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 22184232.779173907
Net income (USD): 1182208.2609276834
EPS growth %: 61.12171768036247
Revenue growth %: 1.5704290530677005
Smoothed growth %: 61.12171768036247
P/E ratio: 18.765080157506134
P/B ratio: 2.4432560714514437
PEG ratio: 0.3070116624607735
Pays dividend: no
Net asset value (USD): 4951898.141959631
Net cash (USD): -1304531.479748696
Net cash to market cap %: -5.880444425255774
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.972364864275428 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4484.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: High)
Market cap (USD): 28667191.991991993
Net income (USD): 569544.5445445445
EPS growth %: -51.82367072129739
Revenue growth %: 10.90526242737085
EPS 2-year CAGR %: -11.896351239467373
Smoothed growth %: -51.82367072129739
P/E ratio: 0.33817601385168955
P/B ratio: 3.1669203208662586
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 5906281.281281281
Net cash (USD): -1056118.6186186187
Net cash to market cap %: -3.68406720446718
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.398786400468251 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4495.T — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 42917668.352441885
P/B ratio: 2.501459913327845
Pays dividend: no
Net asset value (USD): 14297891.585451301
Net cash (USD): 7384597.745079304
Net cash to market cap %: 17.20642809492036
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4495.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 61340392.072377525
P/B ratio: 3.0986384950431787
Pays dividend: no
Net asset value (USD): 12482251.591475228
Net cash (USD): 5978127.594796568
Net cash to market cap %: 9.745825536528656
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4495.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 84211148.67092867
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4495.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: High)
Market cap (USD): 59127230.43283678
P/E ratio: 0.12224603046863985
P/B ratio: 4.249030923296499
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 13461658.461735183
Net cash (USD): 7468902.24410204
Net cash to market cap %: 12.631916275168752
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4496.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 33927062.23497689
P/B ratio: 1.793214049661762
Pays dividend: no
Net asset value (USD): 16539340.243731614
Net cash (USD): 4301533.828267265
Net cash to market cap %: 12.678768938127
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4496.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 38229106.00180457
P/B ratio: 2.2668852396605126
Pays dividend: no
Net asset value (USD): 14907465.579467986
Net cash (USD): 6121193.690683064
Net cash to market cap %: 16.011867215503596
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4496.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 36443609.450387485
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4496.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 37316420.90074024
P/B ratio: 2.0853701002705423
Pays dividend: no
Net asset value (USD): 15196965.006729476
Net cash (USD): 4831366.083445492
Net cash to market cap %: 12.947024304117152
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4496.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: High)
Market cap (USD): 36936770.37037037
P/E ratio: 0.11011244671375389
P/B ratio: 1.994427687705025
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 14416773.023023022
Net cash (USD): 5465271.521521522
Net cash to market cap %: 14.796289623376513
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4512.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 78598685.04556629
Net income (USD): 1954950.008195378
P/E ratio: 40.204959060882096
P/B ratio: 0.8353607656729903
Pays dividend: no
Net asset value (USD): 92482797.90198329
Net cash (USD): -1972988.0347484015
Net cash to market cap %: -2.510204889057106
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.8019109525787664 (Grey Zone)
Piotroski F-score: 3 (Weak)
4512.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 62314177.59189189
Net income (USD): 1037957.9579579581
EPS growth %: -46.906163656015885
Revenue growth %: -5.363936381874875
Smoothed growth %: -46.906163656015885
P/E ratio: 60.03535799704895
P/B ratio: 0.6971093132309822
Pays dividend: no
Net asset value (USD): 87872357.35735737
Net cash (USD): 558851.3513513543
Net cash to market cap %: 0.89682857569169
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.5003264292704386 (Grey Zone)
Piotroski F-score: 4 (Weak)
4512.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 50821228.58320127
Net income (USD): 719486.265187533
EPS growth %: -30.682523345837158
Revenue growth %: -21.407807644463116
EPS 2-year CAGR %: -39.33427028993995
Smoothed growth %: -30.682523345837158
P/E ratio: 70.63543953817491
P/B ratio: 0.6399734557251943
Pays dividend: no
Net asset value (USD): 77053770.4701532
Net cash (USD): 1780672.2134178542
Net cash to market cap %: 3.503796077071713
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4462942535853616 (Grey Zone)
Piotroski F-score: 4 (Weak)
4512.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 72814529.6116161
Net income (USD): 430691.0840796685
EPS growth %: -40.13908188123514
Revenue growth %: 1.8839513934627399
EPS 2-year CAGR %: -35.58410293883787
Smoothed growth %: -40.13908188123514
P/E ratio: 169.064399759311
P/B ratio: 0.9383446597639176
Pays dividend: no
Net asset value (USD): 75742781.71367463
Net cash (USD): -2924742.681459699
Net cash to market cap %: -4.016702019583073
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.9622361749690365 (Grey Zone)
Piotroski F-score: 3 (Weak)
4512.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 59493246.84684685
Net income (USD): 1421515.2652652652
EPS growth %: 230.054490982292
Revenue growth %: 19.050691211653316
EPS 2-year CAGR %: 40.560893777115695
Smoothed growth %: 40.560893777115695
P/E ratio: 0.3352589230451826
P/B ratio: 1.0144205645813715
PEG ratio: 0.00826557040107273
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 73617711.46146145
Net cash (USD): -15545877.127127126
Net cash to market cap %: -26.130490351529804
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4945528458665045 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4521.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1013456909.5041797
Net income (USD): 78257662.67824946
P/E ratio: 12.950257838276261
P/B ratio: 0.8940090375259356
Pays dividend: no
Net asset value (USD): 1061375184.3960007
Net cash (USD): 391460416.3251926
Net cash to market cap %: 38.626251659452336
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 5.2998977104380955 (Safe Zone)
Piotroski F-score: 3 (Weak)
4521.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 917723830.5987239
Net income (USD): 40840840.84084085
EPS growth %: -47.812342659970675
Revenue growth %: -12.068067225496785
Smoothed growth %: -47.812342659970675
P/E ratio: 22.470737910983456
P/B ratio: 0.8933446430792562
Pays dividend: no
Net asset value (USD): 972342342.3423424
Net cash (USD): 336088588.5885886
Net cash to market cap %: 36.62197464887929
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.788666851567722 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4521.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 787365387.100832
Net income (USD): 52991283.67670365
EPS growth %: 29.750716649575825
Revenue growth %: -13.177201594062351
EPS 2-year CAGR %: -17.711568613010364
Smoothed growth %: 29.750716649575825
P/E ratio: 14.858394295644858
P/B ratio: 0.8294571612990852
Pays dividend: no
Net asset value (USD): 899980190.1743265
Net cash (USD): 247332276.80929744
Net cash to market cap %: 31.412642829017763
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.833220306948457 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4521.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1081514723.1382837
Net income (USD): 93202780.37695494
EPS growth %: 75.88322816555834
Revenue growth %: 32.11212004878334
EPS 2-year CAGR %: 51.066127577038436
Smoothed growth %: 51.066127577038436
P/E ratio: 11.60388905528505
P/B ratio: 1.0601585025351496
PEG ratio: 0.2272326022328481
Pays dividend: no
Net asset value (USD): 871581339.3931292
Net cash (USD): 196110145.70244622
Net cash to market cap %: 18.132915022495848
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.710278135689983 (Safe Zone)
Piotroski F-score: 8 (Strong)
4521.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: High)
Market cap (USD): 921594977.3773774
Net income (USD): 13413413.413413413
EPS growth %: -85.60835485898232
Revenue growth %: -23.479608842638566
EPS 2-year CAGR %: -49.68848038455447
Smoothed growth %: -85.60835485898232
P/E ratio: 0.4591544212178852
P/B ratio: 1.0620377334588835
Dividend yield: 0.05
Pays dividend: yes
Net asset value (USD): 771559059.059059
Net cash (USD): 125782032.03203204
Net cash to market cap %: 13.64829834359291
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.783175458007839 (Safe Zone)
Piotroski F-score: 3 (Weak)
4524.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 57819499.61071956
Net income (USD): 2319291.9193574823
P/E ratio: 24.929806863957598
P/B ratio: 0.67487424359097
Pays dividend: no
Net asset value (USD): 81920996.55794132
Net cash (USD): -15464677.92165219
Net cash to market cap %: -26.746474849784217
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.590891889679326 (Grey Zone)
Piotroski F-score: 3 (Weak)
4524.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 57271989.07282283
Net income (USD): 3686186.1861861865
EPS growth %: 58.93584397117968
Revenue growth %: 8.810984465590785
Smoothed growth %: 58.93584397117968
P/E ratio: 15.536922493890023
P/B ratio: 0.6697066933982969
PEG ratio: 0.26362433193436174
Pays dividend: no
Net asset value (USD): 82867867.86786787
Net cash (USD): -17289789.78978979
Net cash to market cap %: -30.18891096624105
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.566518728806848 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4524.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 62661450.70324881
Net income (USD): 4602482.8314844165
EPS growth %: 24.857579053711653
Revenue growth %: -3.937186720835042
EPS 2-year CAGR %: 40.86995670866074
Smoothed growth %: 40.86995670866074
P/E ratio: 13.614706017934001
P/B ratio: 0.7814749316066869
PEG ratio: 0.3331225945499696
Pays dividend: no
Net asset value (USD): 78347860.53882726
Net cash (USD): -26069730.58637084
Net cash to market cap %: -41.604096767295566
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.722130822641658 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4524.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 56376507.741277896
Net income (USD): 3655928.351824622
EPS growth %: -20.56617078905011
Revenue growth %: 4.153534809006064
EPS 2-year CAGR %: -0.4112676541908833
Smoothed growth %: -20.56617078905011
P/E ratio: 15.420572373400365
P/B ratio: 0.6941287926473008
Pays dividend: no
Net asset value (USD): 79447934.76807913
Net cash (USD): -25424408.501537226
Net cash to market cap %: -45.097522922516745
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.575639539674693 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4524.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 56131811.81181181
Net income (USD): 3928928.928928929
EPS growth %: 7.467339368619083
Revenue growth %: -6.965825295764197
EPS 2-year CAGR %: -7.606589622624716
Smoothed growth %: 7.467339368619083
P/E ratio: 0.09071469644946348
P/B ratio: 0.7028100435419237
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 79335585.58558558
Net cash (USD): -23892642.64264264
Net cash to market cap %: -42.56524397029157
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.578034717095469 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4536.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 3771366136.5268946
P/B ratio: 1.8680596174669215
Pays dividend: no
Net asset value (USD): 1467754587.4772377
Net cash (USD): -244523042.44291925
Net cash to market cap %: -6.483672854635748
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
4536.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 2981273230.7005744
P/B ratio: 1.5641227879045938
Pays dividend: no
Net asset value (USD): 1408735463.1733725
Net cash (USD): -201189680.5239941
Net cash to market cap %: -6.748448228501223
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4536.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 3597992331.4366174
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4536.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 3511435970.4971066
P/B ratio: 1.9071127025838888
Pays dividend: no
Net asset value (USD): 1326944818.3041723
Net cash (USD): -332745625.8411844
Net cash to market cap %: -9.476055626156791
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4536.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 3971783777.3773775
P/E ratio: 0.09809910903262971
P/B ratio: 1.9403370325200917
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 1409728478.4784784
Net cash (USD): -273185685.6856857
Net cash to market cap %: -6.878161073160783
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4538.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 132830832.45410588
Net income (USD): 12153745.287657762
P/E ratio: 10.929209828759271
P/B ratio: 0.4693758702629521
Pays dividend: no
Net asset value (USD): 279282084.90411407
Net cash (USD): -225012293.06671035
Net cash to market cap %: -169.39763826629175
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5093982511755977 (Distress Zone)
Piotroski F-score: 3 (Weak)
4538.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 115096367.76126127
Net income (USD): 12049549.54954955
EPS growth %: -0.8573138209011492
Revenue growth %: -5.840767326804547
Smoothed growth %: -0.8573138209011492
P/E ratio: 9.551922857196262
P/B ratio: 0.43004954376840854
Pays dividend: no
Net asset value (USD): 265165165.1651652
Net cash (USD): -216238738.73873872
Net cash to market cap %: -187.87624922036818
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.501568815505148 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4538.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 114990311.28717643
Net income (USD): 9092709.98415214
EPS growth %: -24.53900499133551
Revenue growth %: -4.47379371500226
EPS 2-year CAGR %: -13.504880213352111
Smoothed growth %: -24.53900499133551
P/E ratio: 12.646429006049381
P/B ratio: 0.47500430270123567
Pays dividend: no
Net asset value (USD): 238120707.87110406
Net cash (USD): -224650026.4131009
Net cash to market cap %: -195.3643084346999
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.533151323377676 (Distress Zone)
Piotroski F-score: 4 (Weak)
4538.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 133941891.06041974
Net income (USD): -21975671.701644164
EPS growth %: -341.68451143769005
Revenue growth %: 10.635464033702178
Smoothed growth %: 10.635464033702178
P/B ratio: 0.6064941361395757
Pays dividend: no
Net asset value (USD): 210727175.5112953
Net cash (USD): -283531613.4206656
Net cash to market cap %: -211.68255216940875
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3418655660143357 (Distress Zone)
Piotroski F-score: 3 (Weak)
4538.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 117662186.98698698
Net income (USD): 12581331.331331331
Revenue growth %: -3.6967792815106413
EPS 2-year CAGR %: 17.629602709833737
Smoothed growth %: 17.629602709833737
P/E ratio: 0.0627165006513386
P/B ratio: 0.5754357621302449
PEG ratio: 0.0035574539984588273
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 210867117.1171171
Net cash (USD): -315440440.4404404
Net cash to market cap %: -268.0899008577216
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.1985546570316106 (Distress Zone)
Piotroski F-score: 4 (Weak)
4558.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 15000099.423868889
P/B ratio: 0.858672302535145
Pays dividend: no
Net asset value (USD): 16472033.898305085
Net cash (USD): -10912725.871970862
Net cash to market cap %: -72.75102360059029
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4558.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14350032.978478814
P/B ratio: 0.8499453048446897
Pays dividend: no
Net asset value (USD): 16133404.625050126
Net cash (USD): -8713293.677315867
Net cash to market cap %: -60.719677023623994
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4558.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category:  (confidence: Low)
Market cap (USD): 14568347.453224465
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4558.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14972248.731965007
P/B ratio: 0.8764496344587968
Pays dividend: no
Net asset value (USD): 16495975.773889637
Net cash (USD): -9830074.02422611
Net cash to market cap %: -65.65529467353419
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4558.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 13290915.715715716
P/E ratio: 0.16119435762292905
P/B ratio: 0.8364667270742682
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 15829441.941941941
Net cash (USD): -8710010.010010011
Net cash to market cap %: -65.53355838161657
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4559.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 633844547.8675627
Net income (USD): 32574938.53466645
P/E ratio: 19.458042789337007
P/B ratio: 1.4038525794067627
Pays dividend: no
Net asset value (USD): 112183346.99229635
Net cash (USD): -471116021.96361256
Net cash to market cap %: -74.32674518516943
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.8447163373439095 (Grey Zone)
Piotroski F-score: 3 (Weak)
4559.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 697596184.5193695
Net income (USD): 46597672.672672674
EPS growth %: 43.04761503412553
Revenue growth %: 5.225225804056447
Smoothed growth %: 43.04761503412553
P/E ratio: 14.970622876804672
P/B ratio: 1.4147199653898381
PEG ratio: 0.34776892668587733
Pays dividend: no
Net asset value (USD): 176570915.91591594
Net cash (USD): -398909519.5195195
Net cash to market cap %: -57.18344342642306
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.0941741626897565 (Grey Zone)
Piotroski F-score: 9 (Strong)
4559.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 595421155.0760698
Net income (USD): 51051650.81880613
EPS growth %: 9.55837038776724
Revenue growth %: -2.6011689269665315
EPS 2-year CAGR %: 25.188112818252307
Smoothed growth %: 25.188112818252307
P/E ratio: 11.663112661906945
P/B ratio: 1.1295495956486479
PEG ratio: 0.46304035344225514
Pays dividend: no
Net asset value (USD): 240906332.5409403
Net cash (USD): -332680117.53829896
Net cash to market cap %: -55.87307651099438
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.0564678007854686 (Grey Zone)
Piotroski F-score: 8 (Strong)